Martínez M, Mourelle M, Muriel P
Departmenato de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del IPN, México.
J Appl Toxicol. 1995 Jan-Feb;15(1):49-52. doi: 10.1002/jat.2550150111.
The aim of this work was to study if colchicine protects against. CCl4-induced changes in hepatic biochemical parameters by reducing cytochrome P-450, by comparing the effects of colchicine and SKF 525-A, a well-known inhibitor of cytochrome P-450. Our results show that both drugs reduced the cytochrome P-450 content and p-nitroanisole o-demethylase activity to the same extent. However, colchicine afforded a total protection from markers of liver injury, while SKF 525-A protected only partially. The difference in the hepatoprotective activity of both drugs indicates that the beneficial effect of colchicine cannot be attributed solely to the inhibition of the activation of CCl4. Other actions, perhaps at the level of the propagation of lipid peroxidation or a 'membrane-stabilizing' effect cannot be ruled out.
本研究旨在通过比较秋水仙碱和细胞色素P - 450的著名抑制剂SKF 525 - A的作用,研究秋水仙碱是否通过降低细胞色素P - 450来预防四氯化碳诱导的肝脏生化参数变化。我们的结果表明,两种药物均能同等程度地降低细胞色素P - 450含量和对硝基苯甲醚邻脱甲基酶活性。然而,秋水仙碱能完全保护肝脏免受损伤标志物的影响,而SKF 525 - A仅提供部分保护。两种药物在肝脏保护活性上的差异表明,秋水仙碱的有益作用不能仅仅归因于对四氯化碳活化的抑制。其他作用,可能是在脂质过氧化传播水平或“膜稳定”作用,不能排除。